Industry
Medical - Instruments & Supplies
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Loading...
Open
33.52
Mkt cap
308M
Volume
26K
High
35.24
P/E Ratio
-45.77
52-wk high
43.25
Low
33.52
Div yield
N/A
52-wk low
26.00
Portfolio Pulse from Benzinga Newsdesk
May 15, 2024 | 12:37 pm
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 1:16 pm
Portfolio Pulse from Benzinga Newsdesk
April 18, 2024 | 1:16 pm
Portfolio Pulse from Benzinga Newsdesk
March 27, 2024 | 1:57 pm
Portfolio Pulse from Benzinga Insights
March 25, 2024 | 9:33 am
Portfolio Pulse from Benzinga Insights
March 22, 2024 | 2:00 pm
Portfolio Pulse from Benzinga Newsdesk
February 22, 2024 | 2:16 pm
Portfolio Pulse from Benzinga Newsdesk
February 06, 2024 | 2:50 pm
Portfolio Pulse from Benzinga Newsdesk
January 03, 2024 | 2:18 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.